title: Daclatasvir plus sofosbuvir for HCV infection.
authors.forename: Mark S
authors.initials: MS
authors.lastname: Sulkowski
authors.forename: Ira M
authors.initials: IM
authors.lastname: Jacobson
authors.forename: David R
authors.initials: DR
authors.lastname: Nelson
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors*
chemical_list: D000998:Antiviral Agents; D007093:Imidazoles; D017361:Viral Nonstructural Proteins; D014542:Uridine Monophosphate